NexgenRx Inc.

NXG

CA65337X1042

Investment Management & Fund Operators

Market Closed - Toronto S.E. Other stock markets 19:14:32 03/06/2024 BST			5-day change	1st Jan Change
0.29 ^CAD	+1.75%		+1.75%	+31.82%

05-17	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-16	Charles Burns Tenders Resignation as Director of NexgenRx Inc	CI

Nexgenrx Inc. Announces Resignation of Patrick Crowley as Independent Director

May 24, 2018 at 08:11 pm

NexgenRx Inc. announced, at annual general meeting, the resignation of Patrick Crowley as independent director to take effect immediately.

Latest news about NexgenRx Inc.

NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Charles Burns Tenders Resignation as Director of NexgenRx Inc	05-16	CI
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-05	CI
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	12-29	CI
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	12-20	CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-23	CI
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23	CI
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	15/06/23	CI
NexgenRx's Q1 Profit Falls, Revenue Rises	19/05/23	MT
NexgenRx Inc. Appoints Dave Bennett as New Director	19/05/23	CI
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/05/23	CI
NexgenRx Swings to Loss in Q4	10/04/23	MT
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	06/04/23	CI
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/11/22	CI
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	23/09/22	CI
NexgenRx Announced Q2 2022 Financial Results	19/08/22	MT
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/08/22	CI
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/05/22	CI
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22	CI
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022	20/01/22	CI
NexgenRx Third-Quarter Profit Falls 15% on Higher Spending	19/11/21	MT
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	18/11/21	CI
Nexgenrx Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	18/08/21	CI
NexgenRx Inc. Announces Executive Changes	10/06/21	CI
NexgenRx Inc. Reports Earnings Results for the First quarter Ended March 31, 2021	25/05/21	CI

NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications in a of software-as-a-service model. The Companyâs products include NexSys, NexAdmin, NexPension and NexPSPAssist. The NexSys product platform provides solution and simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. Its NexPension product is an advanced pension administration solution designed to help sponsors record and tabulate contributions for their membership group in a multi-employer environment. Its platform makes self-administration a reality.

Sector

Investment Management & Fund Operators

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
NEXGENRX INC.	+31.82%	14.95M
BLACKROCK, INC.	-5.31%	114B
UBS GROUP AG	+8.89%	102B
BROOKFIELD CORPORATION	+7.51%	64.37B
BANK OF NEW YORK MELLON CORPORATION (THE)	+15.87%	45.1B
AMERIPRISE FINANCIAL, INC.	+12.32%	42.37B
3I GROUP PLC	+20.86%	35.9B
T. ROWE PRICE GROUP INC.	+7.30%	25.8B
STATE STREET CORPORATION	-3.49%	22.52B
PRINCIPAL FINANCIAL GROUP, INC.	+0.76%	18.58B

Other Investment Management & Fund Operators

NexgenRx Inc.

Equities

NXG

CA65337X1042

Investment Management & Fund Operators

Nexgenrx Inc. Announces Resignation of Patrick Crowley as Independent Director

Latest news about NexgenRx Inc.

Chart NexgenRx Inc.

Company Profile

Income Statement Evolution

Sector Other Investment Management & Fund Operators